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The use of static in vitro pHui tary cul tu res has been i ndi spens i bl e for examining the regulation of anterior pituitary hormone secretion.
While the static cultures have shown the effects of various chemical
stimulators of hormone secretion, the dynamics of such secretion has not
been assessed before in vitro. The in vitro superfusion method, which
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partially simulates in vivo physiologic conditions, allows for the observation of the dynamics of pituitary honnone secretion.
Enzymatically dispersed anterior pituitary cells were su

used

with Krebs-Ringer Bicarbonate buffer (KRB, 0.5 mls/min) and various stimulators in order to assess the dynamics (rapidity, duration and magnitude)
of thyrotropin (TSH) secretion. Thyrotropin-releasing honnone (TRH),
diburtyry cyclic AMP, stalk rredian eminence extract (SME), potassium ion,
somatostatin and TSH were used to stimulate the cells. The superfusate was
collected in 1,0 ml fractions and TSH concentration determined by radioifTITlunoassay.
Dispersed cells maintain a stable baseline secretion of TSH when
superfused with KRB and respond rapidly to two-minute pulses of TRH, SME
and potassium. Dibutyryl cyclic AMP elicited no TSH response when pulsed
for two or ten minutes. Somatostatin inhibits the TRH-mediated secretion
of TSH while not having an inhibitory effect on baseline, potassiummedi ated and SME-mediated TSH secretion. Finally, TSH is shown to inhibit
TRH-mediated TSH secretion when TRH is presented to the cells in the
presence of 0.5 or 1.0 ug TSH/ml.
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CHAPTER I
INTRODUCTION

The physiological function of the hypothalamus, hypophysis and
the hypothalamic-hypophyseal portal vascular system has been the
object of much investigation in many in vivo and in vitro systems for
the past several decades.

Recently, a new in vitro model system has

been developed which offers anew approach to neuroendocrine research.
The model system utilizes a continuous media flow through a chamber
containing pituitary cells.

This superfusion system partially simu-

lates conditions found in vivo.

Analysis of superfusate fractions

collected allows investigators to observe dynamic secretory responses
to stimulation, responses not observed before in static pituitary cell
cultures.

Several endocrine systems have been investigated using the

superfusion technique, but only recently has the technique been used
for the study of thyrotropin (TSH) release (Connors and Hedge, 1980;
Connors et al., 1979; Smith and Vale, 1980).
This study utilizes the superfusion system to observe dynamic TSH
responses when cells are stimulated with substances believed to inhibit
or elicit TSH secretion. These responses are compared with results from
static in vitro and superfusion experiments of other investigators.
investigated are TSH shortloop feedback and the effects of repeated
stimulation of pituitary cells on the dynamics of TSH secretion.

Also

CHAPTER I I

LITERATURE REVIEW
Anterior pituitary hormone secretion is under the control of the
hypothalamus by way of the hypothalmic-hypophyseal portal system
(Martin et al., 1977).

Most early physiological and biochemical studies

utilized in vivo experiments in which isolation of individual control
mechanisms is exceedingly difficult.

But the approach to neuroendocrine

studies broadened in the mid-1950 s to include in vitro methods,
1

providing a method to isolate some of the experimental variables.

In

spite of widely varying conditions of cultures and methods of analysis
used, one major conclusion was drawn:

cultured anterior pituitary

tissue can maintain hormone secretion for a limited period of time
(Gaillard and Schaberg, 1965; Tixier-Vidal, 1975). The in vitro studies
offered an improved method for examining the putative hypothalamic
releasing factors which had been indicated in earlier in vivo studies
(Green and Harris, 1947; Harris and Jacobsen, 1952).
The in vitro preparations of pituitary tissue allowed investigators
to study pituitary hormone secretion while avoiding problems associated
with the in vivo studies.

Some of the problems encountered in vivo

included the physical inaccessability of the pituitary gland, undetectable plasma concentrations of pituitary hormones, cellular heterogeniety
of the pituitary gland, and unknown, uncontrollable variables attributed
to the systemic environment (Farquar et al., 1975; Tixier-Vidal, 1975).
Pituitary cultures circumvented some of the problems of accessability,
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allowed the collection of hormone secret·ions from the culture medium,
and eliminated the unknown variables of the systemic environment
(Tixier-Vidal, 1975). The problem of cellular heterogeniety of the
gland was dealt with at a later time by Hymer et al. (1975).
The value of in vitro pituitary culture was realized after the
initial in vitro experiments provided evidence of a specific releasing
factor unique to the hypothalamus.

In 1955, two teams of investigators,

working independently, reported the release of adrenocorticotropin from
cultured whole pituitaries.

Other important discoveries were made

through the culture of whole pituitaries or hemi-pituitary glands for
the next fifteen years (Gaillard and Schaberg, 1965) including the
identification of the six hormones secreted by the anterior pituitary
gl and (Tab 1e I ) .
The in vitro culture methods permitted valuable changes in the
experimental design for pituitary studies.

A single gland could be

divided in order to use one half of the gland for experimental treatments, the other as an experimental control.

Hemi- or quartered

pituitaries respond well to releasing factors found in vivo.

It was

noted, however, that even small molecular weight molecules exhibited
poor penetration of pieces of tissue (Farquar et al., 1975). When
pituitaries were divided into ten pieces, diffusion was still restricted.
Another approach was to use thinly sliced pituitaries, but they displayed poor tissue survival,

presumably due to autolysis by the

release of. lysomal enzymes from ruptured cells (Farquar et al., 1975).
These problems of diffusion restriction and cell death, along with
the inability to make time course measurements of hormonal secretion

4

TABLE I
ANTERIOR PITUITARY AND HYPOPHYSIOTROPIC HORMONES
Anterior Pituitary
·
Hormone

Hypophysiotropic
Hormone

Thyrotropin

Thyrotropin-releasing Hormone

Adrenocorticotropin

Corticotropin-releasing Factor

Luteinizing Hormone

Gonadotropin-releasing Hormone

Follicle Stimulating Hormone

Gonadotropin-releasing Hormone

Growth Hormone

*Growth Hormone-releasing Factor
Growth Hormone-release-inhibiting
Hormone (somatostatin)

Prol act in

*Prolactin-releasing Factor
*Prolactin-release-inhibiting
Factor

*Existence presumed, structure not yet elucidated
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and variability in responses of hemi-pituitaries of variable cell
composition, limited the researcher (Nakano et al., 1976). The need
for an improved in vitro technique became apparent.

Such a technique

was soon developed following the work of Rodbell (1964) who used
enzymes to prepare suspensions of isolated fat cells to study the
effects of insulin-mediated glucose transport across the cell membrane.
Following this lead, Portanova et al. (1970) reported the successful
enzymatic dispersion of anterior pituitary cells which retained their
responsiveness to hypothalamic extracts.

Many different agents were

tried for cell dispersion (e.g., trypsin, hyaluronidase, neuraminidase,
collagenase and EDTA) (Hopkins and Farquar, 1973; Moriarty et al.,
1978; Vale et al., 1972) in order to find the dispersion method which
would yield cells with secretory responses most like those found in
vivo.

The culture of dispersed cells has been used to investigate the

secretion of the six anterior pituitary hormones, and the results
obtained using this method have been accepted as valid (Pantie, 1975).
The cell dispersion technique provides a means of obtaining a
large number of homogeneous cell populations in which to examine the
effects of various agents or manipulations which would not be possible
using randomly selected quartered or hemi-pituitaries of unacceptable
cell heterogeneity (Farquar et al., 1975; Hopkins and Farquar, 1973;
Vale et al., 1972).
Another benefit of cell dispersion is related to the different
cell types found in the anterior pituitary.

It is known that pituitary

thyrotrophs, TSH secreting cells, are clustered in the center portion
of the pituitary gland.

When whole pituitary glands are cultured, the

6

thyrotrophs tend to be sequestered from direct contact with secretagogues by the more exterior cells (Nakane, 1975).

Cell dispersion

eliminates this restictive barrier of cells and allows the thyrotrophs
full exposure to the culture medium.
Cell culture methods have continued to be important for the study
of pituitary cells in vitro; however, the method was augmented by a
modification introduced in 1967 by Tait et al.

This group of researchers

equipped an adrenal tissue culture with a continuous media flow to
observe the acid-stimulated release of aldosterone.

Cell exposure to

secretagogues could be easily and accurately introduced into the medium
as a pulse
11

11

and the response observed in a dynamic fashion.

This

continuous flow system is presently known as the superfusion system.
The superfusion system was first used for the study of anterior
pituitary hormone secretion by Serra and Midgely (1970).

Adding hypo-

thalamic extract to the medium superfusing whole pituitary glands
resulted in the secretion of luteinizing hormone, a dynamic secretory
response never before recorded.

The superfusion method made possible

the collection of culture media throughout the course of cell stimulation with various agents.

Collecting small fractions of this superfusion

media permitted the determination of the hormone secretory profile that
included rates (grams/minute), response time, duration of response,
and amplitude of response.
The anterior pituitary cell superfusion system provided information which approached that obtained with in vivo methods and avoided
some of the complexities of an intact, in vivo system, such as negative
feedback, circadian rhythms, and hypothalamic inhibitors.

After the
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cells have equilibrated with the continuous flow of fresh nutritive
media, the administration of secretagogues (agents which stimulate

hormone secretion) is permitted without mechanically disturbing the
cells.

The possible inhibition of hormone secretion attributed to

negative feedback is greatly reduced as the secreted hormones and
waste products are not permitted to remain in contact with the cells
for any significant period.

The dynamics of hormone release are

easily measured by assaying the fractions of superfusate collected for
hormone content.
Thyrotropin Releasing Hormone
The central nervous system had been long suspected of having a
controlling influence on anterior pituitary function, but it was the
report by Greer (1952) that provided more convincing evidence.
concluded that the hypothalamus mediated the secretion of thyroid
stimulating hormone (TSH) by his demonstration that normal increases
in plasma TSH levels following dietary supplements of propylthiouraci.l
did not occur in rats which had had electrolytic lesions in the area
Experiments designed to study hypothalamic control of the pituitary-thyroid axis continued for the next ten years
with interest primarily centered around the hypothalamic-hypophyseal
system and the investigation of thyrotropin release (Greer, 1960).
The first evidence for a specific hypothalamic hypophysiotropic
factor was obtained by Schally et al. (1966) using hypothalamic
extracts to stimulate TSH secretion in vivo.
(1970)

Later, Wilber and Porter

reported thyrotropin releasing activity in hypophyseal portal
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blood. This evidence lead ultimately to the elucidation of the structure of porcine (Nair et al., 1970) and ovine (Burgus et al., 1970)

thyrotropin releasing hormone (TRH). Thyrotropin releasing hormone
is a tripeptide of pyroglutamyl-histidil-proline amide (m.w. 362)
(Nair et al., 1970). This tripeptide has been synthesized and has
been shown to possess all the biochemical activities of the natural
peptide.

As the first hypothalamic releasing factor to be isolated

and characterized, the elucidation of TRH was a landmark in the field
of neuroendocrinology.
The availability of synthetic TRH has led to numerous investi·
gations of TRH activity.

It has been well accepted that TRH stimulates

the secretion of TSH in vivo.

Many investigators have demonstrated

TSH secretion in response to TRH stimulation in both in vivo and in
vitro systems (Connors and Hedge, 1981; Dannies and Markell, 1980;
Gershengorn et al., 1980; Martin et al., 1977; and Vale et al., 1967).
The potency of TRH induced TSH secretion has been estimated to be·
100,000 fold (Martin et al., 1977). Thyrotropin releasing hormone

has been found in man, pig, rat, hamster, chicken, frog, snake, salmon,
and sea lamprey.

This evidence indicates that TRH occurs widely among

the vertebrate classes (Jackson and Reichlin, 1974).
Control of Thyrotropin Secretion
ecretion of TSH from the anterior pituitary is generally accepted
to be stimulated by TRH from the hypothalamu~Figure 1). Regulation
of TRH stimulated TSH secretion is uncertain, but has been proposed
to be accomplished by three possible mechanisms:

inhibition of TSH

9
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Figure 1.

The hypothalamic-hypophyseal portal system.
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secretion by thyroid hormone feedback (Chopra et al., 1978), suppression by somatotropin release-inhibitory hormone (somatostatin) (Snow
et al., 1978), or the down-regulation of specific TRH receptors on
the thyrotroph cell surface (Peck and Gershengorn, 1980).
The pituitary-thyroid axis has served the science of endocrinology as a favorite example of a negative-feedback self-regulating
syst e~(Martin et al., 1977). The total regulatory
in Figure 2,

schem~

as shown

~olves the interaction of hormones from the hypothalamus,

anterior pituitary, and the thyroid gland:J First, TRH is released from
the hypothalamus, is bound to receptors on the thyrotrophs, and elicits
the release of TSH into the blood.

Thyrotropin stimulates thyroid

gland metabolism and secretion of the thyroid hormones, thyroxine (T4)
and triiodothironine (T3).
11

feedback

11

The thyroid hormones in the blood then

to the pituitary gland, and possibly the hypothalamus, to

inhibit TSH secretion (Chopra et al., 1978). The negative feedback
effect of T4 and T3 on TRH stimulation appears to be the primary control
mechanism of TSH secretion (Martin et al.,

1977

Somatostatin is recognized as a specific inhibitor of growth
hormone secretion but has also been shown to inhibit the secretion of
both TSH and prolactin (Chopra et al., 1978). The effectiveness of
somatostatin as an inhibitor of TSH secretion is limited in that while
somatostatin will decrease the responsiveness of thyrotrophs to TRH
stimulation, it will not decrease the basal secretion of TSH (Drouin
et al., 1976).

If somatostatin plays a role in the regulation of TSH

secretion, it is probably secondary to the T4/T3 feedback regulation
described above.

11

HYPOTHALAM

TRH

l.

TSH
+

THYROID
GLAND

13 & T4

Figure 2. Diagram of the hypothalamic-pituitary-thyroid axis.
(+) = positive stimulation, (-) = negative stimulation.
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A third mechanism of control proposed is associated with the
number of TRH receptors on the thyrotroph.

Data have been interpreted

to give evidence that TRH regulates the number of its own receptors
(Gershengorn, 1978; Hinkle and Tashjian, 1975). Knowing that one
TRH receptor activated by one molecule of TRH has the capacity to
affect the release of TSH 100,000 fold, it is easy to see that small
decreases in the available TRH receptors would result in a very large
decrease in TSH secretion.
Thyrotropin Releasing Hormone and the Second Messenger Theory
Thyrotropin releasing hormone stimulates TSH release by binding
to an extracellular TRH receptor on the thyrotroph (Grant et al., 1973).
Cyclic 3', 5 adenosine monophosphate (cyclic AMP) is believed to
1

serve as an intracellular messenger of anterior pituitary hormone
secretion (Labrie et al., 1978), and has been implicated as a second
messenger of TRH-mediated TSH secretion (Moriarty et al., 1978;
Steiner et al., 1970; Wilber et al., 1968).

However, this role for

cyclic AMP in TSH secretion is not shared by all investigators (Bowers,
1971; Gershengorn et al., 1980; Sundberg et al., 1976).
The second messenger theory for hormone release was first suggested ·after the discovery of cyclic AMP and the adenyl cyclase enzyme
(Sutherland et al., 1968). According to this theory, the first
messenger is an extracellular hormone which binds to a cell membrane
receptor.

The binding of the first messenger activates the intra-

cellular, membrane-bound adenyl cyclase enzyme to convert adenosine
triphosphate to cyclic AMP and inorganic phosphate. The newly formed

13
cyclic AMP is released from the membrane bound enzyme into the cytoplasm as a second messenger, carrying the "command" of the first

messenger. The cyclic AMP activates other enzymes in the cell (protein kinases). These protein kinases, activated after binding to
cyclic AMP, mediate other specific cellular activities (Figure 3).
The cyclic AMP is quickly converted to the inactive 5'-AMP by the
enzyme phosphodiesterase, and the message of the second messenger is
ended (Steer, 1975).

\

'--y-1

r=:=1
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I

I
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I I
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Figure 3.
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CHAPTER III
MATERIALS AND METHODS
Animals
Pituitary cells used for the superfusion experiments were
obtained from Lewis male rats (Charles River, 60-130 days old), kindly
provided by Dr. Wesley Bullock. The rats were housed in the Oregon
Health Sciences University School of Dentistry Animal Care and Research Facility which was maintained at a constant temperature of 12°c,
with a 12 hr light/dark cycle; the rats were fed rat chow (Wayne
Lab Blox F-6) and tap water ad libitum.
Tissue Collection and Cell Preparation
Media used for the superfusion experiments were Hankes-HEPES
buffer (H-H) and Krebs-Ringer buffer (KRB) with glucose and bovine
serum albumin (BSA) (See Appendix for chemical composition).

Both

buffers were maintained at a constant temperature of 25°C and pH 7.3,
and equilibrated with a 95% 02 - 5% C02 atmosphere.
The rats were killed by sudden decapitation within twenty seconds
after removal from their cages.

The pituitaries were quickly removed

and washed three times in H-H buffer.

Posterior lobes were removed

and the anterior lobes washed a fourth time.

The anterior lobes were

minced into approximately twenty pieces each with scissors in a siliconized watchglass containing H-H buffer.

The minced pieces were then
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suspended in 5.0 ml H-H buffer containing collagenase (3.0 mg/ml,
Sigma Type II-S) and BSA (5.0 mg/m1, Sigma A-8022).

This pituitary

cell suspension was then agitated (60 cycles/min in a Dubnoff Metabolic Shaking Incubator, GCA Corp.) for 40 minutes.

The cell suspen-

sion was mechanically agitated every 10 minutes by repeatedly drawing
and expelling the suspension using a siliconized pasteur pipet.

After

40 minutes of dispersion, the suspension was mixed with the pipet 100
times.

The cell suspension was then filtered of connective tissue

and debris using a fine nylon mesh (Nitex #102). The nylon mesh was
then washed with 5.0 ml H-H buffer.

After centrifuging the filtered

cell suspension, the supernatant was aspirated and the pellet resuspended in 2.5 ml KRB.
To count the total number of cells, 50 ul of the cell suspension
were added to 100 ul KRB and 100 ul diluting fluid.

After mixing

well, 25 ul of the suspension were deposited into a hemacytometer
chamber. The four corner squares and the center square of the counting
grid were counted.

The following formula was used:
total cells counted

_

- - - - - - - - - x 5 - no. ce 11 s / m1 •

2.0 x 10- 5 ml

Care was taken to count only nucleated pituicytes.
To assess the viability of the dispersed pituitary cells, the
trypan b1ue dye exclusion procedure was followed as outlined by Merchant et al. (1964).
10 5

-

A 0.5 ml volume of cell suspension (diluted to

2 x 10 5 cells/ml) was placed in a 12 x 75 mm glass test tube with

0.1 ml of 0.4% trypan blue (GIBCO).

The cell suspension was mixed
.

thoroughly and allowed to stand for five minutes.

.

The number of viable

17
cells was determined as outlined by Davidson and Henery (1969) using
25 ul of the trypan blue/cell suspension.

The test is based on the

ability of the viable cells to exclude the dye; therefore, the fiormula
for calculating the viability is as follows:
No. clear cells
- - - - - - - x 100 = o via
total no. cells
0

i

1ty.

Superfusion Method
The superfusion column was constructed using a 3 cc disposable
syringe (Monoject) for a column (Figure 4).

The plunger in the column

was replaced with an inverted 1 cc syringe trimmed to 2 cm.

The rubber

gasket from the unused plunger of the 3 cc syringe was removed, a 6 mm
hole cut through its center, and cemented to the 1 cc barrel to insure
a tight seal.

Eighteen gauge needles were put in place on the leur

tips at each end of the column, which were in turn attached to tygon
tubing.

Parafilm was used to seal all joints on the column to prevent

leakage.
The cells rested on an inert bed of Sephadex G-15 (Pharmacia
Fine Chemicals) which had been allowed to swell 72 hours in phosphosaline buffer before use.

A small circle (1 cm diameter) of grade

934 AH glass fiber filter paper (Reeve Angel) placed at the bottom of
the column provided a base for the Sephadex to assure stability of the
bed while not impeding the flow of superfusion medium.

The Sephadex

was poured into the column to a height of 1.5 cm and washed with approximately 10 ml KRB.

After washing and allowing the KRB to drain to the

top of the Sephadex bed, 10 7 viable cells were carefully applied.

18

_ _ tubing

6-

~

-

blunted 18 gauge
needle

lee syringe

--- 3 cc syringe

1ayer of dispersed
cells

k._._..JJ ..L_.JJ

G-15 Sephadex - -

n'\(

blunted 18 gauge ----------needle
_ _ tubing

Figure 4.

The superfusion column.
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Once the cells settled, forming a layer on the Sephadex, the 1 cc
syringe was carefully inserted, the column sealed and checked for
leaks, and superfusion begun.
The flow rate of the KRB superfusion medium was maintained at
0.5 ml per minute, which is comparable to the flow rate of the hypophyseal portal blood flow found in vivo (Goldman and Sapirstein,
1958).

This rate of flow was established using a Sage Tubing Pump

(Model 375-A) and was verified at the beginning and ending of the
experiment. Superfusion medium was collected in 1.0 ml fractions
(2 minute intervals) using a Gilson fraction collector (Figure 5).
Fractions were frozen and stored at -20°c for hormone analysis at a
later time.
Radioimmunoassay of Thyrotropin
The radioimmunoassay (RIA) procedure followed was a double antibody procedure outlined by the NIAMDD with some minor alterations (See
protocol in Appendix).

Thyrotropin for iodination (TSH-I-4), standards

(TSH-RP-1), and TSH antibody were a generous gift of the NIAMDD Rat
Pituitary Agency.

Sheep anti-rabbit serum for the second antibody was

purchased from Gene Stone, Medford, Oregon.
Quality control for the RIA procedure followed the method described by Rodbard (1974).

Rat plasma pool samples were assayed in

triplicate for each RIA.

The parameters monitored were the within-

assay and between-assay variation.

Within-assay and between-assay

variabilities were 13.9% and 22% respectively, both considered acceptable for RIA of TSH (Fukuda et al., 1975; Russel et al., 1975).
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Figure 5. Schematic illustration of the superfusion apparatus.
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Intracellular TSH Content
The intracellular concentration of TSH was determined by using
50 ul of the cell suspension, designated the pre-superfusion sample,
diluted with 0.95 ml distilled water, and frozen for later assay.
Post-superfusion TSH cell content was determined after removing the
entire contents of the superfusion chamber (Sephadex and cells) with
2.0 ml distilled water, and frozen.
Thyrotropin Flow Through the Superfusion Column
The specific design and construction of the superfusion system
used to study TSH secretion was new; thus, it was first necessary to
determine if TSH flows freely through the superfusion system and is
not slowed or trapped by the Sephadex or pituitary cells. This was
tested by superfusing TSH (0.5 ug/ml) through two Sephadex columns, one
containing anterior pituitary cells, the other containing Sephadex only.
The results of these experiments are shown in Figure 6 and Table II. Elevated levels of TSH appear in fractions collected immediately following
superfusion of TSH and return to baseline levels within four minutes
after cessation of TSH superfusion in both columns. The flow of TSH
is neither retarded, nor is TSH retained by the superfusion system.
An "ideal elution curve 11 is added to Figure 6A to indicate the expected
TSH content of the fractions collected during TSH superfusion, assuming
no restriction of TSH flow and no within-assay variation in the TSH-RIA.
Verification of Stable, Basal Thyrotropin Secretion
-Before a response to a secretagogue can be measured in the superfus ion system, it is essential to first establish a constant basal level
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Figure 6. TSH content of superfusate fractions collected every two minutes.
TSH (0.5 ug/ml) was superfused through a column containing G-15 Sephadex
only (A) and one containing Sephadex with 10.4 million anterior pituitary
cells (B). The dotted line in Figure A is the "ideal elution· curve" of
superfused TSH.
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TABLE II
TSH SUPERFUSION AND RECOVERY THROUGH SEPHADEX COLUMNS
WITH AND WITHOUT ANTERIOR PITUITARY CELLS
ug

Column

Sephadex
alone

Sephadex
with cells

TSH

Su perfused

ug .TSH
Recovered

Variation*

2.00

1.85

7.5%

2.51

2.80

11.5%

1.96

1.73

11.5%

2.45

2.67

8.9%

*Within-assay variation for the TSH RIA was 13.9%.
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of TSH secretion.

The TSH response to secretagogues can then be

assessed by comparison with the baseline.

For this reason, the

secretion of TSH from non-stimulated cells was determined, as shown
in Figure 7.

Basal TSH secretion from superfused anterior pituitary

cells was determined from the time the cells were layered on the
column and the flow of medium begun, until 140 minutes. Thyrotropin
secretion during the first 10 minutes was 3.9 ug TSH/ml and established
a relatively stable basal level (0.125 - 0.25 ug TSH/ml) after 90
minutes of superfusion.

Based on these data and the published data

of others, all superfusion experiments were routinely given a preincubation period of 180 minutes to establish secretory equilibration.
Fractions were collected during the last 20 minutes of the pre-incubation period of each experiment in order to confirm baseline stability.
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Figure 7. Non-specific TSH secretion from superfused, dispersed anterior pituitary
cells. TSH secretion during ten-minute intervals from the time the cells were
applied to the column is shown.
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CHAPTER IV
RESULTS
Thyrotropin Secretion in Response to Thyrotropin Releasing Hormone
As the accepted physiologic stimulator of TSH secretion, TRHmedi ated TSH secretion was examined using the superfusion system.
Thyrotropin responsiveness to a two-minute pulse of TRH (10-s M) in
the superfusion system is immediate, as indicated in Figure 8.
Thyrotropin secretion rose to 0.36 ug/ml above baseline and returned
to baseline levels within four minutes of cessation of TRH superfusion.
Repeated Stimulation of Anterior Pituitary Cells with Thyrotropin
Releasing Hormone
lhe effect of repeated TRH stimulation and TSH responsiveness
was examined using the superfusion system.

Two columns were prepared

to be superfused in parallel. The same pools of KRB and TRH (lo-a M)
were used for each.

The two columns (A and B) each contained 10 7

anterior pituitary cells from the same cell pool.

Each cell prepara-

tion received two-minute pulses of TRH repeatedly during the course
of the experiment.

Results are shown in Figures 9 and 10. The cells

in column A (Figure 9) were stimulated with TRH at 0, 1, 2, and 3
hours.

After the initial TRH pulse, total ug TSH secreted in response

to TRH at 1, 2, and 3 hours decreased 26%, 20%, and 17.3% respectively.
The maximum amplitude of the TSH response peak dropped 39.8% after the
first TRH pulse but remained stable thereafter (Table III).
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Figure 9. TSH secretion in .response to two-minute pulses of 10- 9 MTRH. TRH
was superfused at 0, 1, 2, and 3 hours.

0

0.0 ...___ _.....,.._ _ _ _----!

0.5

1.0

N

00

~

(/)

I

::i
..._,

O'>

..........

E

~

0.0

0.5

1.0

0

~

2

1

TIME (hours)

I

I

~
FA
3
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TABLE III
PEAK AMPLITUDE AND TOTAL TSH RESPONSE TO TWO-MINUTE PULSES

OF 10- 0 MTRH FROM SUPERFUSED ANTERIOR
PITUITARY CELLS

Column

Time of
TRH pulse
(hr)

Peak TSH
response
(ug/ml)

Total TSH
response
( ug)

A

0

0.59

1.47

A

1

0.36

1.09

A

2

0.38

0.87

A

3

0.35

0.71

B

0

0.70

1.12

B

3

0.59

1.07
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(Figure 10) was pulsed with TRH at O and 3 hours.

Although total ug

TSH secreted after the first TRH pulse in column B did not change
greatly, the maximum amplitude of the TSH peak response declined 15.7%.
The TSH peak response profiles from column A and column B are
shown in Figure 11. The responses are superimposed to facilitate
comparing the height and breadth of each peak and to more easily
visualize the area under the peak curve which represents the total
TSH secreted.

While the amplitude of the peak responses remained

stable for column A at 1, 2, and 3 hours, the duration of the response
decreased with each successive TRH pulse.

On the other hand, column B

showed no change in response duration while the peak amplitude decreased.
Shortloop Feedback Regulation of TSH Secretion
Shortloop feedback regulation of TSH secretion was investigated
using the superfusion system.

Two questions concerning the shortloop

feedback phenomenon were addressed.

First, would TSH shortloop feed-

back inhibition of TRH-mediated TSH release be dependent on the time
in which the TSH and TRH are presented to the cells? And second, is
there a TSH dose which is critical to the shortloop feedback effect?
To

~etermine

if a time dependent relationship exists between

TSH and TRH presentati9n which would result in a shortloop feedback
inhibition of TSH secretion, the following procedure was followed.
Anterior pituitary cells were superfused with two-minute pulses of
TRH (10-s M) in the presence of TSH (0.5 ug/ml) (Figure 12). Thyrotropin releasing hormone was presented to the cells during the final
two minutes of a ten-minute TSH superfusion (Chart A of Figure 12) and
immediately following a ten-minute TSH superfusion (Chart B of Figure
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Figure 11. Superimposed profiles of TSH peak responses to two-minute 10- 0 TRH pulses.
These peak profiles are from Figures 9 (Column A) and. 10 (Column B). The four Column .A
peaks represent the TSH secretion from TRH pulses at O (•----•), 1 (!~), 2 (o--o), and
3 (·---·) hours. The two peaks from Column B represent the same TRH pulses administered
at.a°(•-•) and 3 (·---·).hours.
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12).

In both cases, the cells are responsive to TRH.

However, when

a two-minute pulse of TRH was presented to the cells at ten minutes
after a TSH superfusion for thirty minutes, the TSH response was
abolished (Chart B of Figure 12). These data indicate that TRHmediated TSH release can be blocked by maintained high levels of TSH
above baseline secretion.
To determine if the inhibitory effect of TSH on the TRHstimulated TSH secretion described above was dose-dependent, three
different concentrations of TSH (0.25, 0.5, and 1.0 ug/ml) were tested.
Thyrotropin releasing hormone and TSH were administered following the
protocol used in Chart B of Figure 12 above.

Thyrotropin responsive-

ness to TRH was unchanged in the presence of 0.25 ug TSH/ml (Chart C
of Figure 13). When TRH was administered in the presence of 0.5 ug
TSH/ml, the TSH response to TRH was attenuated (Chart A of Figure 13).
Finally, TSH at a concentration of 1.0 ug/ml totally abolished the
TRH-stimulated TSH response (Chart B of Figure 13).
Superfusion of Dibutyryl Cyclic 3 ,5'-Adenosine Monophosphate
1

Cyclic adenosine monophosphate (cyclic AMP) has been reported
to be a second messenger involved in the TRH-mediated TSH release from
anterior pituitary cells.

To examine the effect cyclic AMP may have

on TSH secretion from superfused anterior pituitary cells, dibutyryl
cyclic AMP (10-s M) was superfused for two and ten minutes.

In four

experiments, no change in baseline TSH secretion was observed during
dibutyryl cyclic AMP superfusion (data not shown).
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Figure 13.. Thyrotropin secretion in response to TRH
presented to cells alone or accompanied by different
doses of TSH. When 0.5 ug TSH/ml was superfused with
a 10- 0 MTRH stimulus, TRH-mediated TSH secretion
dropped 67% compared to TSH response to TRH alone
(panel A). When 1.0 ug TSH/ml accompanied a TRH
stimulus, TRH-mediated TSH secretion was totally
blocked (panel B). When a TRH stimulus was presented
in conjunction with 0.25 ug TSH/ml, no inhibition of
TRH-mediated TSH secretion was observed (panel C).
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Somatostatin as an Inhibitor of Thyrotropin Secretion
Somatostatin inhibition of TRH-mediated TSH release was examined

next. Cells were stimulated with either TRH (10-s M) or pituitary
stalk-median eminence extract (SME, 1.0 or 0.5 U/ml) in the presence
or absence of somatostatin (10-s M).
when TRH alone was administered.

Pituitary cells were responsive

However, if TRH were presented to

the cells during somatostatin superfusion, no TSH response was observed (Figure 14). Anterior pituitary cells are responsive to both
doses of SME when presented alone or in the presence of somatostatin
(Table IV). These data indicate that somatostatin (10-s M) will block
TRH-mediated TSH release but has no effect on the SME-mediated TSH
release.
Thyrotropin Secretion in Response to High Potassium Ion Concentration
Potassium, another secretagogue, was examined next in the superfusion system for its ability to stimulate TSH release from anterior
pituitary cells.

Dispersed cells superfused with potassium ion at

twenty-five times the normal concentration, for two minutes, responded
with an increase in total TSH secretion (1.34 ug) (Figure 15). The
cells were then superfused with potassium in the presence of 10-s M
somatostatin.

The TSH response to potassium in the presence of somato-

statin was attenuated but not blocked (0.98 ug). When a third twominute potassium pulse was presented, the total TSH secretion dropped
to 0.37 ug.

It should be noted that the baseline TSH secretion was

also diminished after the somatostatin superfusion to levels below
the detectable limit of the TSH-RIA.
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TABLE IV
TOTAL TSH SECRETION IN RESPONSE TO PITUITARY STALK MEDIAN-EMINENCE

EXTRACT (SME) ALONE AND IN THE PRESENCE
OF 10-s MSOMATOSTATIN

SME
(U /ml )

Somatostatin
(concentration)

Total TSH
secreted*
(ug)

0

1.85

1.0

10-s M

1.77

0.5

0

0.925

0.5

10-s M

0.910

1.0**

*One unit SME equals the extract obtained from one rat pituitary
stalk median-eminence.
**TSH responses are given as the total ug TSH secreted above
baseline in response to a two-minute SME pulse.
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normal concentration of KCL were given alone and in the
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Intracellular Thyrotropin Content
The intracellular TSH content of dispersed anterior pituitary

cells was assessed

by

RIA to determine if the intracellular TSH

reserves were exhausted.
in Table V.

The results of two such assays are given

The pre-superfusion TSH cell content for the two super-

fusions was 13.7 and 9.98 pg/cell.

The cellular TSH content after

superfusion dropped to 1.99 and 1.22 pg/cell. This reflects an 85.47%
and an 87.77 drop in intracellular TSH.

1

I•
l
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TABLE V
THE INTRACELLULAR TSH CONTENT OF DISPERSED ANTERIOR PITUITARY

CELLS BEFORE AND AFTER SUPERFUSION

Pre-superfusion
TSH content

Post-superfusion
TSH content

Superfusion
Period*
(hrs)

Percent
Decrease

(pg)

(pg)

13.70

1.99

8.5

85.47

9.98

1.22

6.8

87. 77

*Cells superfused 8.5 hours rece1ved six, two-minute pulses
of 10-s MTRH, while the cells superfused 6.8 hours received
six, two-minute pulses of 3.85 MKCl and twenty-minutes of
10-s Msomatostatin.

CHAPTER V
DISCUSSION
The superfusion system is an in vitro system which simulated,
to an extent, the continuous flow situation found in vivo.

This

method has been utilized previously for the study of anterior pituitary hormones, including thyrotropin (Mulder and Smelic, 1977; Swano
and Kokubu, 1977; Dowd, et al., 1975; Connors, et al., 1981). The
TSH secretory response to TRH (10- 8 M) in this current study are comparable to those previously measured in a superfusion system (Connors,
et al., 1981). Therefore, it has been demonstrated that the pituitary
cell superfusion system used for this study is responsive to TRH and
is physiologically comparable to those of other laboratories.
The magnitude of TRH-mediated secretion from superfused, dispersed
anterior pituitary cells decreased with repeated TRH stimulation.

In

all superfusion experiments conducted for this study, the amplitude of
the initial TSH peak was greater than all subsequent TSH responses.

And

while the amplitude of the later TSH responses remains fairly constant,
the total micrograms TSH secreted per TRH pulse declines (Table III).
These observations are in agreement with those of Nakano, et al. (1976)
and Vale, et al. (1972) who reported a decrease in TSH responsiveness
to TRH with time using static in vitro cultures.
The TSH response to repeated TRH stimulation declines in total
micrograms secreted per TRH pulse, but (after the first TRH pulse) shows

l.
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no decline in the secretion rate for the first two minutes of the
response.

These data conflict with the theory presented by Connors,

et al. (1979) of a "depletable but replaceable pool of intracellular
TSH.

(Connors suggested that TSH exists within the cell in two pools:

(1) a depletable pool that can be replenished relatively rapidly, and
(2) a more slowly secreted, depletion resistant pool.

Connors reported

this after he noted a decrease in the amplitude of the initial peak
TSH response to TRH but no decrease in the lower, plateau level of TSH
secretion that is characteristic of ten or thirty-minute TRH stimulation.)

A comparison of the peak and total TSH responses to repeated

TRH stimulation is shown in Figures 9 and 10 and is given in Table III.
While the peak TSH response in column A remained fairly constant after
the first TRH pulse, the total ug TSH secreted per TRH pulse decreased
with each successive stimulation. This evidence conflicts with the
"depletion resistant pool" suggested by Connors.

If the depletable

pool is replaced rapidly and the non-depletable pool is not affected
by repeated challenges as Connors suggests, then one would expect the
peak TSH responses and total TSH responses to parallel for the TRH
pulses in column A at one, two and three hours.

The data presented

here do not support the proposed theory of a depletion resistant TSH
pool.

Rather, the total TSH response to identical TRH stimulation de-

creases as the superfusion progresses.
Special consideration should be taken when calculating the hormone responsiveness to secretagogues using the superfusion system. The
amplitude of the TSH response to a two-minute TRH stimulation is not
always indicative of the total TSH response.

When looking at the peak

l
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amplitude, one can readily see that peak height does not correlate
directly to the amount of TSH secreted (Figure 11, Table III).

For

this reason, it is important to look very carefully at the entire TSH
response peak and not draw conclusions from the peak amplitude only.
The involvement of shortloop feedback regulation of TSH secretion has not been investigated before using the superfusion system.
Previous studies investigating possible TSH shortloop feedback have
examined changes in the TRH content of the hypothalamus.

Motta, et

al. (1969) noted that bovine TSH, when administered to thyroidectomized
rats, resulted in decreased hypothalamic TRH content as measured by
bioassay.

Roti, et al. (1978) on the other hand,

detect~d

no decrease

in hypothalamic TRH content or pituitary TSH secretion when thyroidectomized rats were given the same amount of bovine TSH.

Roti con-

cluded that the shortloop feedback system reported for other pituitary
hormones was probably not part of the regulatory system for TSH.

The

results of this current superfusion study indicate the TSH can inhibit
TRH-mediated TSH secretion at the level of the pituitary thyrotroph.
The apparent discrepancy between this study and those previously performed may be due to the fact that these experiment examined the effect
of.TSH directly upon the pituitary and that normal, not thyroidectomized,
rats were used for this model system.

I conclude that TSH, when admini-

stered during and throughout the time of expected TSH secretion, can
attenuate such secretion and that this effect is mediated at the level
of thyrotroph.
Cyclic AMP has been reported to be the second messenger involved
in TSH secretion from anterior pituitary cells (Labrie, et al., 1978).
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Results from this study do not give support to this role for cyclic
AMP.

No TSH response was observed when cells were superfused with

3 mM dibutyryl cyclic AMP for two or ten minutes.

These results are

in agreement with others using static cultures (Sundberg, et al.,
1968) and pituitary cell superfusion (Connors and Hedge, 1981).

In

other static cultures, cyclic AMP was shown to elicit a TRH response
only after a three hour incubation with 1.0 or 0.5 mM dibutyryl cyclic
AMP (Leuschen, et al., 1978; Moriarty, et al., 1978).

If dibutyryl

cyclic AMP is to be used to investigate TSH secretion in the superfusion system, a longer exposure time is suggested.
Somatostatin was effective in blocking the TRH-mediated release
f

.l
l1
I'
i

of TSH from anterior pituitary cells while not affecting baseline
secretion.

This observation is in agreement with previous reports

(Connors, et al., 1981; Drouin, et al., 1976).

On the other hand,

when extract of the pituitary stalk median-eminence (SME) was presented
to the cells in the presence of somatostatin, no inhibition of TSH
secretion was noted.
\

No analysis of the SME extract was done; therefore

it is not possible to determine the actual molar concentration of TRH
presented to the cells when superfused with 1.0 or 0.5 U SME/ml.

The

0.5 U SME/ml dose did elicit a TSH response comparable to that elicited
by io-a MTRH (Tables III and IV).

Another point to consider is the

unknown concentration of somatostatin in the SME extract. The median
eminence r.ontains the highest concentration of somatostatin found in
the rat brain (Brownstein, et al., 1975; Kobayashi, et al., 1977).
I

Since the SME extract carries an undetermined amount of both TRH and
somatostatin, more refined experimentation is required before detailed
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comparisons can be made between the effects of somatostatin on TRHmediated and SME extract-mediated TSH secretion.

i!

The TSH responsiveness to potassium observed using the superfusion system are comparable to those reported by Vale and Guillemin
(1967) in static cultures. As with repeated TRH stimulation, the TSH
responses to repeated potassium stimulation decrease in magnitude.
This decrease is detected both in the amplitude of the response as
well as the total quantity of TSH secreted.

For this reason, it is

difficult to determine if the second, attenuated TSH response to potassium seen in Figure 15 is due to somatostatin inhibition or merely
the naturally occurring decline in TSH responsiveness to potassium.
A final consideration when dealing with superfused pituitary
cells is the availability of intracellular TSH for secretion. While
some investigators have reported TSH responses after several days in
static cell cultures (Dannies and Markell, 1980; Vale, et al., 1972),
some of the cell preparations superfused in this study cease to secrete
TSH after only eight to ten hours.

This decrease in TSH responsiveness

may be directly related to the continuous flow of fresh medium. Approximately 80% of the intracellular TSH is lost during the pre-incubation
equilibration period, leaving only 20% available for secretion during
the remainder of the superfusion experiment.

Considering the effect

of extracellular TSH on TSH secretion, it is likely that the tremendous
loss of TSH from the cells during the first forty minutes of the preincubation period of the superfusion (Figure 7) does not occur in static
cultures due to shortloop feedback inhibition.

This could explain the

difference in TSH responsiveness noted between static cultures and

,-
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superfused cells.

:\
1•

Exhaustion of cellular TSH may very likely be a con-

tributing factor to the decline in TSH responsiveness to secretagogues
observed using the superfusion system.

r
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APPENDIX I
RADIOIMMUNOASSAY OF RAT TSH
l

I

.I

!1

I

I

Materials and Reagents:
1. 10 x 75 mm disposable borosilicate glass (or plastic) tubes
2. 0.01 M phosphosaline buffer, pH 7.6 with 1% bovine serum albumin (BSA)
3. 0.01 Mphosphosaline buffer, pH 7.6 with 0.1% bovine serum albumin
(BSA)
4. 0.01 Mphosphosaline buffer, pH 7.6 with 3% normal rabbit serum and
0.05 MEDTA
5. Rat reference preparation, for standards, 10 ug/100 ul, stored
frozen in 100 ul aliquots in 0.01 Mphosphosaline buffer, pH 7.6
with 1% BSA
6. 125-I-TSH repurified within 24 hours of use; diluted to 10,000
cpm/100 ul with 0.1% BSA-PBS
7. TSH antiserum, stored frozen at 1:10 dilution with 0.01 Mphosphosaline buffer-3% NRS - 0.05 MEDTA, pH 7.6 •. This is diluted to the
appropriate titer for the assay (usually 1:10,000 f.d.) and stored in
the refrigerator for up to one month.
8. Second antibody (goat or sheep anti-rabbit gamma globulin)
Assay Procedures:
1. Standards:
Prepare 3 standard curves from 2.5 ng-1000 ng/tube using a micromedic autodilutor. Dilute the thawed TSH reference preparation 1:10
with buffer prior to use for Stock A. Prepare two subsequent 1:10
dilutions.for Stocks B and C. Use 100, 75, 50, ~nd 25 ul of each
stock solution for each standard curve.
2.

Maximum .Binding Tubes (Max or 100% or B0 tubes):
Prepare 4-10 Max tubes distributed in pairs throughout the assay.
Add 0.2 ml 0.01 M PBS - 1% BSA to these tubes.

3.

Blank Tubes:
Prepare 4-10 .blank tubes distributed in pairs (with the Max tubes)
throughout the assay. Add 0.2 ml 0.01 MPBS - 1% BSA to these tubes.

4.

Plasma Pools (Controls):
Prepare 2-4 tubes containing 100 ul (more or less depending upoD
TSH.content) .and 100 ul of PBS buffer. If 4 tubes are prepared, 2
should be placed at the beginning of the unknown samples and 2 at the
end of the samples.

i
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6. Total Count Tubes:

Prepare 5-10 tubes.

I

l

I;

Unknown. Samples (.Plasma, pituitary extract, incubation media,. etc.):
Remove clots and mix. sample well. Pipette 0.2 ml (or. less) into
each assay tube. Add sufficient 1% BSA-PBS buffer to tube to bring
volume up to 0.2 ml if less than 0.2 ml sample is used.

7.

Contain no 1% BSA-PBS buffer.

Adding 125 1-TSH and TSH Antiserum:
These·two reagents are added simultaneously using 2 Micromedic
autodilutor pumps.
a. 125 !-TSH. Add 100 ul to each tube of assay.
b. TSH antiserum. Add 200 ul to each tube of assay EXCEPT blank
and total count tubes.
---

8. .Blank Tubes:
Receive 200 ul of the 3% NRS-0.05 MEDTA-PBS buffer.
9.

Volume in all tubes except total count tubes should be 0.5 ml.
cover with Parafilm and incubate 24 hours at room temperature.

Vortex,

10. Second Antibody:
Add sufficient antibody to maximally precipitate the antibody
found rat TSH (usually 20-100 ul).
11.

Vortex tubes, cover with Parafi1m and incubate at 4°C for 24 hours.

12.

Centrifuge all tubes except total count tubes for 20 minutes at
1000 xg at 4°C.

13.

Aspirate off the supernate immediately.

14.

Count precipitate for 2 min. (or 10,000 counts) using automatic well
type gamma counter.
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TSH IODINATION PROCEDURE

Materials and Reagents:
1. 10 ml disposable plastic pipette for column
2. Glass bead, or glass wool
3. 30 collection tubes, 12 x 75.mm disposable glass
4. Sephadex G-50 (or G-75), in 0.01 MPBS
5. Bovine serum albumin (BSA), 2% and 5% in 0.01 Mphosphosaline buffer
6. Phosphosaline buffer (PBS); 0.01 M, 0.50 Mand 0.05 M, pH 7.6 (potassium or sodium)
·
7. Carrier-free Na 1125 (NEN), 1.5 mCi
8. Chloramine T, 2.8 mg/ml in 0.05 Mphosphosaline buffer, prepared fresh
9. Sodium metabisulfite, 2.4 mg/ml in 0.05 MPBS
10. NIAMD Rat TSH, 5 ug/25 ul in 0.01 M PBS, stored in reaction tube
(10 x 75 mm disposable glass)
11. 0.5 M Phosphate buffer, pH 7.6
Preparation of Sephadex Column:
We generally prepare 2 columns so that there is a spare in case of an
accident to one column or a bad iodination.
.
Swell Sephadex in.0.01 M PBS for 24 hr. (~1 gin 30 ml).
Decant to about 50:50 Sephadex to buffer and put under vacuum for about
30 min. to eliminate bubbles (or allow to reach room temperature without
vacuum).
Cut off mouthpiece of column pipette, put in glass bead and fit tip with
short section of rubber tubing with pinch clamp.
_
Fill column pipette with Pasteur pipette until bed_volume is 7-10 ml.
_ Wash column with 10 ml of 0.01 M PBS which was previously put under
vacuum for about 30 min. and drain meniscus to top of bed.
Coat Sephadex by adding 2 ml of 2% BSA and allowing to drain until
meniscus is at top of bed.
Wash column with 10 ml 0.01 PBS and drain meniscus to approximately 1 ml
above top of bed.
Label and coat the collecting tubes with 4 drops of 2% BSA/tube (only
tubes 5-15 need BSA).
Check to see that all reagents and materials are prepared for the reaction, then drain meniscus to top of bed and clamp column.
Column is used once and discarded.
Labeling Procedure:
Make chloramine T and sodium metabisulfite immediately prior to use~
1. Thaw rat TSH (5 ug in 25 ul) in reaction vial.
2. Add 25 ul 0.5 M phosphate buffer to vial, mix gently.
3. Add 1.5.mC Na 125-I in 15 ul 0.5 M PBS, mix gently.
4. Add 20 ul of ch1oramine T (56 ug) and agitate gently for exactly
40 seconds.
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5.

Add 50 ul of sodium metabisulfite (120 ug), mix rapidly and apply
reaction .mixture .to the Sephadex column.
6. Rinse vial with a few drops of 0.01 M PBS and add to top of column.
7. "Drain meniscus to top of column and slowly begin adding 0.01 M PBS
a few drops at a time, allowing meniscus to drain after each applica-

tion. Do NOT ALLOW SEPHADEX TO BECOME DRY. Collect 8-9 drop frac-

8.

tions as they are eluted from the column. Add more PBS as needed.
(Fill column once meniscus has drained several times.).
Count tubes to determine the location of the two peaks; one labeled
hormone and one free 125-I.

APPENDIX II
PROTOCOL FOR PITUITARY CELL DISPERSION
Preparatory Steps: .Have agitating water bath pre-heated to 37oc. Label
four plastic disposable petri dishes, 1 - 4, and put 4 ml of Hanks HEPES
buffer (pH 7.3) in each. Keep dishes heated to 37oc the entire time they
are in use.
Cell Dispersion:
1.
2.
3.
4.
5.
6.
7.
8.

9.

10.
11.

12.

Sacrifice animals by sudden decapitation. Collect trunk blood in test
tube if desired. Record the time of sacrifice of the first and last
animal.
,
Quickly remove the pituitary gland and place in dish #1. Carefully
remove the stalk median eminence and place in 0.1 N HCl on ice.
Wash pits through dishes 1, 2, and 3.
Remove posterior lobes and discard. Place an anterior lobe in dish #4.
With scissors or a razor blade, mince or dice the pits in a fifth
siliconized glass watchglass or petri dish. Separate each pit into
approximately twenty pieces.
Place all pieces into 5 ml of Hanks-HEPES buffer (H-H buffer) in a
15 ml conical centrifuge tube .. Then wash dish #5 with 5 ml H-H buffer
and collect in the same centrifuge tube.
Spin cells at 240 g for 10 minutes. Aspirate supernatant.
Resuspend pellet in. 5 ml Collagenase solution. Agitate the cells in
solution in a waterbath at 37oc for 30 min. Mix the cell suspension
every 10 min. with a siliconized Pasteur pipet. Draw the cells into
the pipet approximately 25 times the first two times and 100 times
on the third and final mix.
Filter the cell suspension through nylon mesh (Nilex #102) into a
second conical centrifuge tube. Wash the mesh with 5 ml H-H buffer.
Spin the cells at 240 g for 20 min., check the supernatant for cells.
If supernatant is clear, aspirate.
Wash cells in 5 ml H-H buffer and spin at 240 g for 20 min. Aspirate
off.supernatant.
Resuspend cells 1n 2 ml of buffer to be used in experiment. Test for
cell number and viability.
Dilute the 2 ml cell suspension to desired cell concentration.

Equipment for Cell Dispersion:
4 small petri dishes
1 siliconized watch glass or petri dish
siliconized Pasteur pipets
curved tipped Pasteur pipet
nylon mesh
water bath
hemacytometer
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microscope
adjustable pipet
15 ml conical centrifuge tubes
surgical tools:
small curved forceps

large curved forceps

scissors
scalpel
Rongeur forceps
razor blade (siliconized)

APPENDIX II I
SUPERFUSION MEDIA COMPOSITION AND PREPARATION

Hanks-HEPES Buffer (H-H buffer):

500 ml

To 450 ml double distilled water, add the following reagents:
G.M.W.
NaCl
KCL
Na2NP04
KH2P04
MgS04
MgCh
CaCl2
glucose
NaHC03
HEPES (Sigma)

58.44
74.55
141.96
136.09
120.40
203.23
147.03
180.16
84~01

238.30

Cone. (mM)
129.0
4.0
1.0
0.6
0.2
0.5
1.0
6.0
15.0
25.0

.9_r./500 ml
3.77
0.149
0.071
0.041
0.012
0.051
0.0735
0.540
0.630
2.979

Adjust pH to 7.3 and Q.S. to 500 ml
Krebs-Ringer Bicarbonate Buffer (KRB):
KRB buffer is prepared with NaCl, KCl, CaCl2, KH2P04, and MgS04 solutions
made up at 5 times the final concentration and stored at 4°C.
Solution #
1.

2.
3.

4.
5.

NaCl
KCl
CaCl2
KH2P04
MgS04

Cone. (mM)
154.0
154.0
110.0
154.0
154.0

5x Cone. {mM)
770.0
770.0
550.0
770.0
770.0

KRB buffer is made up fresh daily as follows: Solutions 1-5 which.had
been prepared previously were diluted at the ration 1:2:3:4:5 = 100:4:3:1:1.
This solution was then diluted 1:5 in double distilled water to which was
added 26 parts NaHC03 (154.0 mM). The. KRB solution was adjusted to pH
7.3 after which glucose (11.0 mM) and bovine serum albumin (BSA 0.5 mg/
ml) were added. The KRB is maintained at 37oc in a 95% 02 - 5% C02
atmosphere for the duration of the experiment.
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Diluting Fluid for Cell Count
Diluting fluid for the cell count procedure is made up as outlined by
Davidson and Henery (1969) and modified by Hedge (personal communication) as follows:
·
1% w:v crystal violet
1% v:v glacial acetic acid
2 drops 5% phenol
100 ml double distilled water

